Equine focused shock wave therapy started in Germany in 1996. The following 5 standard indications used in human medicine were initially adapted for use in horses: (1) calcifying tendonitis of the shoulder (tendinosis calcarea), (2) tennis elbow (lateral epicondylitis), (3) golfer's elbow (medial epicondylitis), (4) heel spurs (plantar fasciitis), and (5) pseudarthrosis. Because of positive experiences treating people with insertional desmopathies and the large size of the machines and probes, the first equine disease to be treated was proximal suspensory desmitis. Initial clinical responses were positive. The company High Medical Technologies (HMT) developed the first machine designed specifically for equine use. The Equitron (HMT, Lengwil, Switzerland) was a modified machine originally used in people. It had a solid frame, a probe on a flexible cord, and a maximum energy flux density (EFD) of 0.15 m~/ m r n~. This machine made it possible to reach nearly every part of a standing horse. Since promising results were achieved in horses with proximal suspensory desmitis, shock wave therapy was attempted in numerous locations. In 1997, horses with navicular syndrome were first treated. Initially, the probe was positioned behind the navicular bone from the heel, but when ultrasonographic imaging showed the distal impar ligament could be seen through the frog, this location was then used to administer shock wave therapy to the distal part of the navicular area.
cycling and degassing. Its use was limited to anesthetizecl horses. Shock wave therapy became more cost effective and popular once a modified machine for use in the standing horse became available.
Over the last 5 years much has been learned about use in horses with extracorporeal shock wave therapy (ESWT) use in horses for orthopedic disease. Experimental data are lacking and only now becoming available. As with any new therapeutic modality, clinical use precedes objective data. There are often claims of effectiveness that are later modified. As with many new therapies, case selection can be a problem since horses refractory to other methods are managed with the "new kid on the block therapeutic approach. Below, we have included data currently available and our personal experiences and opinions. We fully expect that ESWT will continue to evolve quickly over the next several years.
How to Use Focused Shock Waves
There is a continual debate on how best to focus shock waves to manage a lesion. Some clinicians use direct ultrasound guidance and some just estimate an area of interest. Since focused shock waves are a locally concentrated therapy without regional or systemic effects, it is absolutely necessary to have a clear and concrete diagnosis to define the treatment area. Diagnosis is limited by resolution of imaging equipment. For instance, Weiler and coworkers3 found histopathological evidence of desmitis in horses judged healthy, based on clinical lameness inspection and an ultrasonographic examination. The clinical relevance of this finding is unknown, but diagnostic imaging may be still a limiting fa~tol''.~ One of us defined a three-dimensional method of treating lesions with focused shock waves. The approximate location is identified using ultrasonographic and radiographic examinations and a probe is positioned on the area without ultrasonographic guidance. The probe is then moved to treat an area larger than that viewed ultrasonographically or radiographically. The depth is also varied for complete treatment. The equipment will dictate how the depth is varied; however, for suspensory ligament we would use 20-mm and 35-mm probes. No negative side effects (energy level up to 0.15 m~/ m m~) have been observed after 3500 treatments in horses.
The other concept of treatment is to treat just a very small defined area with parallel ultrasonographic guidance during the treatment to maintain the probe strictly on the previously identified lesion. Further experience will hopefully show if there are differences between the 2 techniques. Both authors use the three-dimensional approach to treatment. If high energy levels are used, it may be best to use ultrasonographic guidance and concentrate ESWT on the specific lesion, rather than the surrounding tissue since damage to healthy soft tissue structures could occur. Magnetic resonance imaging (MRI) may better define lesion size and volume, but is currently only of limited value.
At the time of this writing, both authors are using similar electrohydraulic shock wave generators (EquitronIHMT); where energy levels and pulse numbers are discussed, they pertain to this equipment. Veterinarians using different shock wave generators with different energy density and focal sizes should consult with others using the same shock wave generaLor to achieve the best results.
Bone Spavin
In one of the first reports of use of ESWT in horses, Dr. McCarroll treated 74 horses with lameness ranging from grade 1 to 3 (0 being sound and 5 being nonweight bearing) that had distal hock joint pain refractory to traditional the rap^.^ Each joint was administered 2000 pulses at 0.89 mJ/mmL with the primary focus point at the site or sites of radiographically apparent lesions. In the 74 horses, a total of 139 joints were treated. Ar the time of follow-up examination 90 days after treatment, 80% had improved ar least 1 lameness grade. Of the 15 horses with no improvement, 8 returned for a second treatment and 4 of these horses improved. Follow-up radiographs taken at 90 days after treatment showed no consistent changes when compared with radiographs taken before treatment. Horses with osteophyte formation on the dorsal or dorsomedial aspect of the tarsometatarsal joint were most likely to improve. Following treatment there does not appear to be an accelerated ankylosis of the joints. Subsequent to the 90-day follow-up period the horses that responded to treatment have continued to perform as expected without the lameness worsening to the pretreatment grade.
Shock wave therapy is most commonly used as an adjunct to intraarticular therapy. In horses that do not have adequate resolution with medical therapy alone, they can be treated with intraarticular medication and ESWT simultaneously. There appears to be an additive effect of the 2 therapies. The horse is sedated, clipped, and restrained in stocks. Eight hundred to 1000 pulses at 0.15 mJ/mm2 are delivered to the affected joints, usually split between the 5-mm and 20-mm probes. The probe is moved around the joint medially, laterally, and dorsally and positioning is done by palpation. Horses that previously required the combination treatment may have both ESWT and intraarticular medication at the same visit. Horses that do not respond adequately to injections alone may be treated at another visit.
Navicular Syndrome
The chronic debilitating nature of navicular syndrome has led to the investigation of ESWT as a potential therapeutic modality. In 16 horses, blinded evaluators graded lameness before and 6 months after ESWT was administered with an electrohydraulic shock wave generator while the horses were under general anesthesia in lateral recumbency (McClure SR, unpublished data, 2002). ESWT was directed at each affected navicuIar bone, and a total of 2000 pulses (1000 pulses through the frog and 1000 through the heel) at 0.89 m~/mrn' were administered. After treatment, horses were given stall rest for 1 week, then given limited hand walking and ground work for an additional 5 weeks before resuming full work.
Before treatment, mean lameness grade was 1.8 (range 0 to 5) when trotted in a straight line on a hard surlace. Lameness scores were consistently worse when the affected forelimb was on the inside of a circle (mean 2.6, range I to 4). After treatment, score ranges from 0 to 3 in a straight line and 0 LO 4 whcn circled. Mean lameness score while trotting in a straight line and when circled decreased 0.7 and 0.9, respectively. When trotted in a straight line 9 of the 16 horses (56%) were improved, 2 had no change, and in 5 horses, lameness worsened. Similarly when evaluated in a circle 9 of 16 (56%) were improved, 1 had no change, and in 4 horses lameness had progressed.
Case selection criteria may improve these results. It appears that horses with radiographically visible enthesopathy ot the navicular suspensory ligament do not respond well to ESWT. Perhaps this region is difficult to target. Horses with erosions on the flexor cortex of the navicular bone do not improve after ESWT likely because of the presence of the adhesions between the deep digital flexor tendon and navicular bone and DDF tendonitis (Fig 1) .
To treat the navicular region it is important to prepare the foot. After the foot is trimmed and the frog pared, we prefer to soak the foot in a bandage for 8 to 12 hours. This softens the frog and improves the transmission of the shock waves. To treat the entire navicular region, we aim from 2 directions, from the frog and from between the heel bulbs (Fig 2) . This can be easily done in the standing, lightly sedated horse. The veterinarian can sit on a short stool, flex the carpus, and rest the metacarpus on the veterinarian's leg. One hand can hold the shock wave probe and the other stabilizes the leg.
The energy setting and pulse number will vary between generators. Foot conformation makes a big difference in depth. The lateral radiograph can be taken with a metallic marker or the ultrasound can be used to direct the shock waves to the correct depth and location.
Tendonitis
ESWT is used to treat numerous tendon diseases in people. When compared with bone, tendons and ligaments are at risk of damage from excess energy or number of pulse^.^ While the results of laboratory studies in rabbits cannot be directly extrapolated to horses, some early treatments with high energy equipment set at 0.89 m~/ m m * resulted in increased inflammation in tendons and ligaments. Similar problems have not been seen with the portable HMT generators.
People with dystrophic mineralization of the Achilles, patellar, and rotator cuff tendons are managed successfully with ESWT. Pain relief and dissolution of calcified areas of tendon were reported.' Our experiences in horses are similar. We have observed dissolution of areas of dystrophic mineralization in horses using ESWT, similar to that seen in people with calcification of the rotator cuff tendons. Small areas of mineralization seen ultrasonographically can be resolved with ESWT, but large areas of mineralization seen radiographically are not altered. Excessive treatment may result in worsening of tendonitis/ desmitis.
Eight Thoroughbred race horses with superficial digital flexor (SDF) tendonitis sustained during racing or race training were treated with ESWT (Hunter J, McClure SR, Merritt DK, unpublished data, 2003). All horses had core lesions (type 3) and were treated using an electrohydraulic generator. Approx- Crpluatim of the 
~d t~~E 3 W T r c v c r b~~t a b k d . c c r c r a t i n t h t a~i d w i r M a

ExcessiveenergyorpulsenunaberJrnayMto~necro5is.
Since there is a dose-dependent rehdorpship of UWT, it is therefore important to keep in mind that "mom is not net--ily better." Gadtissue inmfams &odd be w&kd hawse of Two studies have been dam in rats to investigate the poten-tial for a central effect of ESWT.23 .N Paws of rats were treated with variable energy densities with either 1 or multiple treatmenls and spinal cords were examined histologically with stains for opioid and nonopioid neurotransmitters. No significant effect after ESWT was found. Shock waves induced nearly complete degeneration of epidermal nerve fibers in rat skin as determined by measuring immunoreactivity of substance P and calcitonin gene-related peptide, 2 neuropeptides. Normal histologic staining did not return for 14 daysz5 We studied nerves and neurotransmitter substances serially following shock wave therapy in a sheep model. RPWT and ESWT were used to treat the mid metacarpaVmetatarsal regions in 30 sheep.2" Nerve, skin, and periosteum were collected from each leg from 2 sheep immediately after treatment and at daily intervals for 14 days in the remaining 28 sheep. The treatment consisted of 1000 pulses of ESWT at 0.15 m~l m m l or 1000 pulses of RPWT at 0.16 m~/ m m l .
The skin and periosteum were evaluated for concentrations of substance P and CGRP. The nerves were fixed and evaluated histologically. There were no differences between treated and untreated limbs in neuropeptide concentrations. However, the effect of time after treatment was significant for perineural inflammation and axonal swelling; there was more inflammation after treatment for both ESWT and RPWT. Nerve inflammation may contribute to the analgesic effect.
Analgesia after ESWT is evident in some horses. All horses are not affected similarly since some have a notable decrease while sonie have an increase in lameness for a few days after treatment. Pain relief after shock wave therapy in horses with proximal suspensory desmitis was studied by using a force plate instrumented treadmill. At 24 hours after shock wave treatment, analgesia was similar to that induced by local or perineural analgesia, and the duration was 3 days."
The effect of shock waves on cutaneous sensation in the horse was investigated in 2 wayszb Skin sensation in the treatment area of the mid metacarpavmetatarsal region and the skin sensation distal to a treatment site on the palmar digital nerve were measured. Horses were equipped with small electrodes taped to the skin surface and a constant current stimulator was used to pass a small wave of electrical current through the electrodes. The milliamperes were gradually increased until the horse first responded to stimulation. In the mid metacarpal region there was a difference from baseline for both ESWT and RPWT for the first 4 days after treatment. This indicated that skin sensation was attenuated directly under the treatment site for 4 days after treatment. Skin distal to the nerve treatment site was unaffected.
The palmar digital nerves in horses were evaluated by nerve conduction velocity and histology after RPWT in the pastern region. 28 The conduction velocities were slower in treated nervesat 3 and 7 days after treatment. Histologically, there were segmental areas of demyelination and axonal swelling in all treated nerves as well as disruption of myelin sheaths of largediameter axons.
A t the time of this writing the analgesic effects have led to regulations governing the use of shock wave therapy in performance horses. Three of the major racing states, California, Florida, and New York, have declared that horses may not race within 10 days of treatment with shock wave therapy. There are no regulations governing German Thoroughbred racing. The USA Equestrian organization has remained silent on the use of shock waves. In Europe the Federal Equestrian International limits the use of shock wave therapy 5 days before competition.
